.
MergerLinks Header Logo

New Deal


Announced

PFM Health Sciences led a $100m Series C round in Caresyntax.

Synopsis

PFM Health Sciences led a $100m Series C round in Caresyntax, with participation from Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital, Arno Capital, Rezayat Investments, IPF Partners, the Relyens Group, and Surgical.AI. "Operating rooms need to perform as effectively and efficiently as possible, and this is especially true now to make up for the surgical backlog driven by the pandemic. With better technology to safely automate surgical pathways while generating decision-grade real-world evidence, we will improve health care decision-making, mitigate surgical risks, and advance high-value medical technology," Dennis Kogan, Caresyntax Founder and CEO.

Show Details & Financials

Market Context

Sort

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US